Methylphenidate Improves Brain Function in Boys with ADHD
Author Information
Author(s): Katya Rubia, Rozmin Halari, Abdul-Majeed Mohammad, Eric Taylor, Michael Brammer
Primary Institution: King's College London
Hypothesis
Methylphenidate (MPH) will upregulate and normalize underactivated areas of error detection in ADHD patients relative to control subjects.
Conclusion
MPH normalized brain dysfunction in medication-naive boys with ADHD, improving activation in key areas related to performance monitoring.
Supporting Evidence
- ADHD boys showed underactivation in key brain areas during error processing when on placebo.
- MPH significantly increased activation in these areas, normalizing differences with control subjects.
- Behavioral improvements were observed alongside changes in brain activation.
Takeaway
Boys with ADHD who took a medicine called methylphenidate showed better brain activity when they made mistakes, helping them focus and do better in school.
Methodology
The study used fMRI to compare brain activation in 12 medication-naive boys with ADHD under a single dose of MPH and placebo during a stop task.
Potential Biases
Potential bias due to the unequal number of scans between ADHD patients and control subjects.
Limitations
The control group was scanned only once, and the sample size was relatively small.
Participant Demographics
12 medication-naive boys aged 10 to 15 years with ADHD, and 13 healthy age-matched boys.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website